DUBLIN--(BUSINESS WIRE)--The "Continuous Renal Replacement Therapy, And Segment Forecasts, 2014 - 2025" report has been added to Research and Markets' offering.
The global continuous renal replacement therapy (CRRT) market is expected to reach USD 1.4 billion by 2025
The magnitude of the global target diseases, such as kidney diseases, and diabetes, is immense, with millions of new cases registered every year. This in turn is anticipated to boost the usage of CRRT treatment procedure.
Increasing incidence of volume overload, uremia, and hyperkalemia is increasing the application of renal replacement therapy, thereby boosting the overall growth of the market. For individuals suffering from acute kidney injury and severe multi-organ dysfunction, CRRT can prove to be beneficial when started early to maintain metabolic and volume homeostasis. In addition, CRRT prevents further worsening and development of symptoms and signs of renal failure.
Key Topics Covered:
Chapter 1 Research Methodology
Chapter 2 Executive Summary
Chapter 3 Continuous Renal Replacement Therapy Market Variables, Trends & Scope
Chapter 4 Continuous Renal Replacement Therapy Market: Product Estimates & Trend Analysis
Chapter 5 Continuous Renal Replacement Therapy Market: Modality Estimates & Trend Analysis
Chapter 6 Continuous Renal Replacement Therapy Market: Regional Estimates & Trend Analysis, by Product & Modality
Chapter 7 Competitive Landscape
- Braun Melsungen AG
- Baxter International, Inc.
- Fresenius Medical Care AG & Co. KGaA
- Asahi Kasei Corporation
- NIPRO Corporation
- Toray Medical Co., Ltd.
- NxStage Medical, Inc.
- Medtronic plc
For more information about this report visit https://www.researchandmarkets.com/research/kdj2cj/continuous_renal
